Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MALHELMIN: SMC and Anthelminthic Co-administration
NCT05354258Unknown
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Jun 2022
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of praziquantel and albendazole in schistosomiasis and soil-transmitted helminthiasis (STH) (3 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoint: Incidence of Treatment-Emergent Adverse Events at 6 days. Status: unknown.
02
Drugs
praziquantelalbendazole
03
Conditions
schistosomiasissoil-transmitted helminthiasis (STH)
Beyond the preview
Go deeper on NCT05354258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05354258.